Cargando…

A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant

Posttransplant lymphoproliferative disorder (PTLD) comprises a spectrum ranging from polyclonal hyperplasia to aggressive monoclonal lymphomas. The majority of PTLDs are of B-cell origin while T-cell PTLDs and Hodgkin lymphoma-like PTLDs are uncommon. Here, we report a unique case of a 56-year-old m...

Descripción completa

Detalles Bibliográficos
Autores principales: La Fortune, Kristin, Zhang, Dahua, Raca, Gordana, Ranheim, Erik A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662176/
https://www.ncbi.nlm.nih.gov/pubmed/23738160
http://dx.doi.org/10.1155/2013/386147
_version_ 1782270816716587008
author La Fortune, Kristin
Zhang, Dahua
Raca, Gordana
Ranheim, Erik A.
author_facet La Fortune, Kristin
Zhang, Dahua
Raca, Gordana
Ranheim, Erik A.
author_sort La Fortune, Kristin
collection PubMed
description Posttransplant lymphoproliferative disorder (PTLD) comprises a spectrum ranging from polyclonal hyperplasia to aggressive monoclonal lymphomas. The majority of PTLDs are of B-cell origin while T-cell PTLDs and Hodgkin lymphoma-like PTLDs are uncommon. Here, we report a unique case of a 56-year-old man in whom a lymphoma with two distinct components developed as a duodenal mass seventeen years following a combined kidney-pancreas transplant. This PTLD, which has features not previously reported in the literature, consisted of one component of CD20 positive and EBV negative monomorphic diffuse large B-cell lymphoma. The other component showed anaplastic morphology, expressed some but not all T-cell markers, failed to express most B-cell markers except for PAX5, and was diffusely EBV positive. Possible etiologies for this peculiar constellation of findings are discussed and the literature reviewed for “composite-like” lymphomas late in the posttransplant setting.
format Online
Article
Text
id pubmed-3662176
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36621762013-06-04 A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant La Fortune, Kristin Zhang, Dahua Raca, Gordana Ranheim, Erik A. Case Rep Hematol Case Report Posttransplant lymphoproliferative disorder (PTLD) comprises a spectrum ranging from polyclonal hyperplasia to aggressive monoclonal lymphomas. The majority of PTLDs are of B-cell origin while T-cell PTLDs and Hodgkin lymphoma-like PTLDs are uncommon. Here, we report a unique case of a 56-year-old man in whom a lymphoma with two distinct components developed as a duodenal mass seventeen years following a combined kidney-pancreas transplant. This PTLD, which has features not previously reported in the literature, consisted of one component of CD20 positive and EBV negative monomorphic diffuse large B-cell lymphoma. The other component showed anaplastic morphology, expressed some but not all T-cell markers, failed to express most B-cell markers except for PAX5, and was diffusely EBV positive. Possible etiologies for this peculiar constellation of findings are discussed and the literature reviewed for “composite-like” lymphomas late in the posttransplant setting. Hindawi Publishing Corporation 2013 2013-05-07 /pmc/articles/PMC3662176/ /pubmed/23738160 http://dx.doi.org/10.1155/2013/386147 Text en Copyright © 2013 Kristin La Fortune et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
La Fortune, Kristin
Zhang, Dahua
Raca, Gordana
Ranheim, Erik A.
A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant
title A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant
title_full A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant
title_fullStr A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant
title_full_unstemmed A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant
title_short A Unique “Composite” PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant
title_sort unique “composite” ptld with diffuse large b-cell and t/anaplastic large cell lymphoma components occurring 17 years after transplant
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662176/
https://www.ncbi.nlm.nih.gov/pubmed/23738160
http://dx.doi.org/10.1155/2013/386147
work_keys_str_mv AT lafortunekristin auniquecompositeptldwithdiffuselargebcellandtanaplasticlargecelllymphomacomponentsoccurring17yearsaftertransplant
AT zhangdahua auniquecompositeptldwithdiffuselargebcellandtanaplasticlargecelllymphomacomponentsoccurring17yearsaftertransplant
AT racagordana auniquecompositeptldwithdiffuselargebcellandtanaplasticlargecelllymphomacomponentsoccurring17yearsaftertransplant
AT ranheimerika auniquecompositeptldwithdiffuselargebcellandtanaplasticlargecelllymphomacomponentsoccurring17yearsaftertransplant
AT lafortunekristin uniquecompositeptldwithdiffuselargebcellandtanaplasticlargecelllymphomacomponentsoccurring17yearsaftertransplant
AT zhangdahua uniquecompositeptldwithdiffuselargebcellandtanaplasticlargecelllymphomacomponentsoccurring17yearsaftertransplant
AT racagordana uniquecompositeptldwithdiffuselargebcellandtanaplasticlargecelllymphomacomponentsoccurring17yearsaftertransplant
AT ranheimerika uniquecompositeptldwithdiffuselargebcellandtanaplasticlargecelllymphomacomponentsoccurring17yearsaftertransplant